V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260018751 | 260014627 | 1.8 | 77.8 | Curative (C) | 2017-11-30 | 2017-12-21 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260029433 | CISPLATIN + METHOTREXATE + VINCRISTINE |
| 260018752 | 260009736 | 1.53 | 64.3 | Curative (C) | null | 2019-03-16 | Methotrexate High Dose (3g/m2) | N | null | 260029448 | CYTARABINE HD + METHOTREXATE HD |
| 260018753 | 260018203 | 1.67 | 100 | Palliative (P) | 2015-10-09 | 2015-10-14 | TRASTUZUMAB | N | N | 260029461 | NIVOLUMAB |
| 260018754 | 260009740 | null | null | Curative (C) | 2017-11-18 | 2017-12-22 | VAI (Ifos 3g/m2) | N | N | 260029465 | MAP |
| 260018755 | 260009744 | 1.82 | 75.8 | Adjuvant (A) | 2016-11-20 | 2016-11-28 | STS Rhabdomyosarcoma RMS 2005 VA | 02 | N | 260029472 | BLEOMYCIN |
| 260018756 | 260009752 | 1.55 | 57.1 | Curative (C) | 2018-11-29 | 2019-02-02 | Pemetrexed | N | N | 260029507 | DOCETAXEL |
| 260018757 | 260014638 | 1.78 | 0 | Palliative (P) | null | 2016-06-03 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260029509 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018758 | 260009765 | null | 83.3 | Curative (C) | 2016-01-25 | 2016-05-14 | OST Euramos 1 Closed Trial - M | N | N | 260029528 | CISPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260018759 | 260009769 | 1.79 | null | Adjuvant (A) | 2020-01-11 | 2020-02-06 | Vinblastine | N | N | 260029532 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260018760 | 260014645 | 1.67 | 77.8 | Curative (C) | 2016-11-04 | 2016-12-24 | Carboplatin + Thiotepa + Topotecan | 2 | N | 260029535 | CISPLATIN |
| 260018761 | 260018210 | 1.65 | 64 | Curative (C) | 2016-11-29 | 2016-11-29 | Cisplatin + Radiotherapy | 2 | N | 260029557 | NIVOLUMAB |
| 260018762 | 260018803 | 1.74 | 64.1 | Palliative (P) | 2018-07-26 | 2018-09-26 | CISPLATIN + ETOPOSIDE + PACLITAXEL | null | null | 260029590 | GEMCITABINE + OXALIPLATIN |
| 260018763 | 260009807 | 1.81 | 61.7 | Palliative (P) | 2016-02-04 | 2016-06-15 | Vinblastine weekly | N | N | 260029660 | ICE |
| 260018764 | 260014664 | 0 | 69 | Curative (C) | 2017-01-11 | 2017-01-20 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | N | N | 260029667 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018765 | 260014666 | 1.72 | 65.5 | Curative (C) | 2015-02-13 | 2015-02-26 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 260029688 | CARBOPLATIN + PEMETREXED |
| 260018766 | 260009816 | 1.75 | 91.6 | Disease modification (D) | 2018-04-06 | 2018-04-10 | STS Rhabdomyosarcoma RMS 2005 VA | 2 | N | 260029691 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018767 | 260009820 | null | 64 | Curative (C) | 2015-07-26 | 2015-09-14 | CVP | N | N | 260029695 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260018768 | 260009821 | null | 85.7 | Palliative (P) | 2018-06-24 | 2018-06-29 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | null | 260029697 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260018769 | 260017035 | 1.68 | 64 | Curative (C) | 2014-04-04 | 2014-06-04 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260029746 | CYTARABINE HD + METHOTREXATE HD |
| 260018770 | 260014675 | null | 67.4 | Curative (C) | 2019-01-24 | 2019-02-14 | IPO | N | N | 260029754 | PAC-PLAT |
| 260018771 | 260017041 | 1.85 | 95.6 | Palliative (P) | 2016-09-25 | 2016-10-03 | Cisplatin + Vinorelbine (IV) | 02 | N | 260029834 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260018772 | 260009864 | 1.76 | 54.4 | Disease modification (D) | 2017-04-23 | 2017-06-18 | TRASTUZUMAB | N | N | 260029958 | CARBOPLATIN + PACLITAXEL |
| 260018773 | 260009867 | 1.87 | 93 | Curative (C) | 2018-03-22 | 2018-04-13 | IPO | null | null | 260029960 | LANREOTIDE |
| 260018774 | 260009872 | 1.54 | 66 | Curative (C) | 2016-06-22 | 2016-06-27 | BLEOMYCIN + VINCRISTINE | N | N | 260029988 | BLEOMYCIN + VINCRISTINE |
| 260018775 | 260009874 | 1.63 | 81 | null | 2017-05-02 | 2018-09-23 | Cisplatin + Vinorelbine (IV) | N | N | 260030000 | IVADO |
| 260018776 | 260009876 | 1.63 | null | Curative (C) | 2017-05-09 | 2017-06-26 | STS Rhabdo RMS 2005 Vin Cyclo | N | Y | 260030008 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260018777 | 260009880 | 1.57 | 66.7 | Curative (C) | 2016-11-20 | 2016-11-20 | Carboplatin + Paclitaxel (3 weekly) | N | N | 260030019 | CHOP |
| 260018778 | 260014698 | 1.73 | 95.8 | Curative (C) | 2017-06-12 | 2017-06-28 | Temozolomide 200mg/m2 | null | null | 260030030 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260018779 | 260017050 | 1.76 | null | Disease modification (D) | 2018-07-15 | 2018-07-24 | BLEOMYCIN | 02 | Y | 260030041 | CARBOPLATIN + ETOPOSIDE |
| 260018780 | 260009891 | 1.87 | 73.5 | Curative (C) | 2019-07-03 | 2019-07-03 | STS Rhabdomyosarcoma RMS 2005 VA | 2 | N | 260030070 | CISPLATIN + VINORELBINE |
| 260018782 | 260009896 | 1.6 | 96.2 | null | 2017-02-25 | 2017-08-16 | BLEOMYCIN + VINCRISTINE | N | N | 260030077 | CISPLATIN |
| 260018783 | 260009903 | 1.76 | null | Curative (C) | 2015-06-27 | 2015-07-04 | Carboplatin + Paclitaxel (3 weekly) | N | null | 260030095 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260018784 | 260009908 | 1.83 | 66.8 | Curative (C) | 2019-02-18 | 2019-02-18 | IVE | 2 | N | 260030119 | ESHAP |
| 260018785 | 260014713 | 1.71 | 86 | Curative (C) | 2014-07-19 | 2014-07-21 | CARBOPLATIN + IFOSFAMIDE + PACLITAXEL | N | N | 260030125 | CISPLATIN + GEMCITABINE |
| 260018787 | 260009926 | 1.69 | 75.6 | Adjuvant (A) | null | 2019-01-16 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | 02 | N | 260006047 | GEMCITABINE + TIP |
| 260018788 | 260009928 | 1.58 | 68 | Curative (C) | 2017-12-23 | 2017-12-25 | NIVOLUMAB | N | N | 260006875 | CISPLATIN + RT |
| 260018789 | 260009937 | 0 | 51 | Curative (C) | 2016-06-06 | 2016-06-06 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260007261 | CARBO + THIOTEPA + TOPOTECAN |
| 260018790 | 260009948 | 1.61 | 74 | Adjuvant (A) | 2019-01-10 | 2019-01-10 | CVP | 02 | Y | 260007834 | OBINUTUZUMAB |
| 260018791 | 260009953 | 1.57 | null | Curative (C) | 2018-08-15 | 2018-08-15 | DOCETAXEL + TRASTUZUMAB | 02 | N | 260007862 | NIVOLUMAB |
| 260018792 | 260009960 | 1.84 | 76.7 | Palliative (P) | 2015-04-05 | 2015-10-27 | PAC-PLAT | N | null | 260007890 | GEMCITABINE + PACLITAXEL |
| 260018793 | 260009977 | 1.67 | 63.7 | Palliative (P) | 2018-01-21 | 2018-01-21 | Docetaxel + Trastuzumab (Maint) | 02 | N | 260008307 | BLEOMYCIN + VINCRISTINE |
| 260018794 | 260009980 | 1.78 | 77.4 | Neo-adjuvant (N) | 2015-06-04 | 2015-06-04 | NIVOLUMAB | 2 | N | 260008373 | FEC |
| 260018795 | 260009984 | 1.8 | 92.9 | Disease modification (D) | 2018-07-14 | 2018-07-21 | VIP | 02 | N | 260008455 | IVA |
| 260018796 | 260019115 | 1.84 | 96 | Palliative (P) | 2016-11-28 | 2016-12-19 | GEM-P | N | null | 260008561 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 260018797 | 260009986 | 1.66 | 69.7 | Curative (C) | 2015-08-07 | 2015-08-18 | DOCETAXEL + TRASTUZUMAB | 2 | N | 260008571 | IBRUTINIB |
| 260018798 | 260009997 | 1.75 | 88 | Curative (C) | 2016-06-24 | 2016-06-27 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 02 | N | 260008930 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260018799 | 260010001 | 1.83 | 82.4 | null | 2017-06-02 | 2017-06-07 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 260008975 | METHOTREXATE |
| 260018800 | 260010017 | 1.76 | 86.8 | Curative (C) | 2019-03-19 | 2019-03-28 | CISPLATIN + ETOPOSIDE + PACLITAXEL | N | N | 260009422 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 260018801 | 260010021 | null | 61.2 | Palliative (P) | 2017-08-08 | 2017-08-08 | CVP | N | N | 260009510 | CVP |
| 260018802 | 260018235 | 1.75 | 92.2 | Palliative (P) | 2016-01-11 | 2016-02-27 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260009752 | POMB |